•Stanford researchers developed a nasal‑spray universal vaccine targeting multiple respiratory illnesses
•In animal studies, the spray protected against colds, flu, COVID, RSV, bacterial infections, allergies
•Researchers say human clinical trials are required before the vaccine can be used in people